Stroke Trial, Recruiting NCT05277519 Sponsor: Institut National de la Santé Et de la Recherche Médicale, France Condition: Stroke
Back to Stroke

Stroke Trial, Recruiting

NCT05277519
Recruiting Not Applicable

Who may be able to join

AI generated eligibility summary. Written by an AI model from the official source data and checked on a sample basis. It can contain mistakes, so confirm anything important against the original source. How we use AI

Who might be able to join this trial:

  • People who have experienced at least some weakness on one side of their body (including one leg) following a brain injury such as a stroke or traumatic brain injury
  • People who speak French
  • People who are enrolled in the French social insurance system
  • People who had no previous brain injuries from trauma, blood vessel problems, or degenerative conditions before their current injury
  • People who had or currently have some degree of movement difficulty in one of their legs
  • People who were unable to walk independently when they entered the rehabilitation department
  • People who are in the sub-acute phase of recovery, meaning between 15 days and 6 months after their brain injury occurred
  • People who have only mild to moderate cognitive (thinking or memory) difficulties that still allow them to understand instructions and give informed consent to participate

Who may not be able to join:

  • People with severe cognitive (thinking or memory) difficulties
  • People who are under a court order, guardianship, or legal protection arrangement that affects their ability to make decisions
  • People who are pregnant or currently breastfeeding
  • People who are outpatients and do not have at least weekly appointments at the rehabilitation department

Important: Always verify eligibility with the trial site directly before applying.

Based on publicly available eligibility criteria from ClinicalTrials.gov. Verify directly with the trial site before acting. This is not medical advice.

This is a simplified plain English summary of the eligibility criteria. Full criteria are set by the trial investigators and may include additional requirements not shown here. Never self-exclude from a trial based on this summary. Contact the trial site directly to confirm your eligibility.
Last synced 27 July 2026
This study is not part of the standard drug-approval phase pathway (for example an observational, device, behavioural, or registry study), so a phase success rate does not apply.

Contact this trial

Principal Investigator: Eleonore Bayen, MD, PhD, Sorbonne University - AP-HP (Pitié-Salpêtrière Hospital)

Phone: +33142161120

Contact details sourced from ClinicalTrials.gov. Verify directly with the trial site before attending.

GP referral letter

Print a one-page summary to share with your doctor.

Trial details

Status
Recruiting
Phase
Not Applicable
Sponsor
Institut National de la Santé Et de la Recherche Médicale, France
Registry
ClinicalTrials.gov
Start date
16 June 2022
Est. completion
15 June 2027

Where this trial is recruiting

🇫🇷 France

Primary endpoints

Baseline EMG; Baseline EEG; EMG change from baseline after 2-week treatment; EEG change from baseline after 2-week treatment; EMG change after the 5-week treatment; EEG change after the 5-week treatment

Can't join this trial?

Expanded access pathways

If this trial is not available to you, other access pathways may exist. In Australia, the TGA Special Access Scheme allows access to unapproved therapeutic goods for individual patients.

TGA Special Access Scheme information

Find other recruiting trials on ClinicalTrials.gov

Data last synced from ClinicalTrials.gov: 27 July 2026. Trial status can change. Always verify current status directly with the trial site before making any decision.

Trial recruitment status can change without notice between our nightly data updates. Always contact the trial site directly to confirm current recruitment status before making any decisions or travel arrangements.

View original record on ClinicalTrials.gov